Glaukos Corporation

This study tests a new eye drop, GLK-321, for people with Demodex blepharitis, an eye condition caused by tiny mites that leads to eyelash dandruff and irritation. About 250 adults with signs of the condition will receive either the drug or a placebo for 6 weeks. The main goal is…

This Phase 3 trial tests a second-generation travoprost implant placed inside the eye to lower pressure in people with open-angle glaucoma or ocular hypertension. The implant slowly releases medication over time, potentially reducing the need for daily eye drops. About 510 adults…

This study tests whether adding a tiny implant that releases medication (iDose TR) to another implant that helps fluid drain (iStent infinite) can lower eye pressure better than the drain implant alone. About 230 adults with open-angle glaucoma or high eye pressure will take part…

This study tests a tiny implant placed inside the eye that slowly releases medication to lower eye pressure. It is for adults with open-angle glaucoma or high eye pressure. The goal is to see if the implant is safe and works better than standard eye drops.

This study tests an updated inserter for a travoprost implant that is placed inside the eye to lower pressure in people with open-angle glaucoma or ocular hypertension. About 30 adults will take part to see if doctors can successfully use the new inserter as instructed. The goal …

This study tests an experimental eye drop called GLK-221 for people with keratoconus, a condition where the cornea thins and bulges outward, blurring vision. The trial will enroll 100 adults aged 18 to 55 and compare the eye drop to a placebo over several months. The main goal is…

This study tests whether a small implant placed inside the eye during cataract surgery can safely lower eye pressure in people with glaucoma or high eye pressure. About 132 adults will receive either the implant plus surgery or surgery alone. The goal is to see if the implant hel…